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jects. They found that depressive symptoms as measured 
with the Beck Depression Inventory-II significantly pre-
dicted interleukin-6 (IL-6) levels after 6 years of follow-up, 
whereas inflammation did not predict depressive symp-
tom scores at follow-up, suggesting that depression leads 
to an up-regulation of IL-6 levels. However, the Whitehall 
study came to the opposite conclusion. In over 3,000 Brit-
ish civil servants followed for almost 12 years, Gimeno and 
colleagues found that inflammation preceded depressive 
symptoms, whereas depressive symptoms did not predict 
inflammation (13).
To our knowledge, whether depressive symptoms are 
the cause or result of inflammation has not been evalu-
ated in patients with cardiovascular disease. We therefore 
set out to evaluate the prospective association between 
depressive symptoms and inflammation using repeated 
measurements of depressive symptoms and inflammation 
in patients with stable coronary heart disease. We evalu-
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O b je c t iv e : 	 Depression	 has	 been	 associ-
ated	 w ith	 inflammation	 in	 patients	 w ith	
coronary	 heart	 disease.	 However,	 it	 is	
uncertain	 whether	 depressive	 symptoms	
lead	to	inflammation	or	vice	versa.
M e tho d : 	The	authors	evaluated	667	out-
patients	 w ith	 established	 coronary	 heart	
disease	 from 	 the	 Heart	 and	 Soul	 Study.	
Depressive	 symptoms	 were	 assessed	 an-
nually	 w ith	 the	 9-item 	 Patient	 Health	
Questionnaire.	 Participants	 were	 catego-
rized	 as	 having	 no	 significant	 depressive	
symptoms	 (score	 below 	 10	 at	 all	 inter-
views),	depressive	symptoms	 (score	of	10	
or	higher)	at	one	interview,	or	depressive	
symptoms	 at	 two	 or	more	 interviews.	 At	
baseline	 and	 5-year	 follow-up,	 fasting	
blood	samples	were	collected	to	measure	
three	 inflammatory	 biomarkers:	 fibrino-
gen,	interleukin-6	(IL-6),	and	high-sensitiv-
ity	C-reactive	protein	(hsCRP).
R e su lts : 	O f	the	667	participants,	443	had	
no	depressive	symptoms,	86	had	depres-
sive	 symptoms	 at	 one	 assessment,	 and	
138	 had	 depressive	 symptoms	 at	 two	
or	 more	 annual	 assessments.	 Across	 the	
three	 groups,	 greater	 depressive	 symp-
toms	were	 associated	w ith	 higher	 subse-
quent	 log-transformed	 levels	 of	 IL-6	 and	
hsCRP,	and	the	association	w ith	higher	fi-
brinogen	 levels	 approached	 significance.	
Baseline	 inflammation	 did	 not	 predict	
subsequent	 depressive	 symptoms.	 The	
association	of	 depressive	 symptoms	w ith	
subsequent	 inflammation	 levels	 was	
elim inated	 after	 adjustment	 for	 health	
behaviors	 associated	 w ith	 depression—
physical	 inactivity,	 smoking,	 and	 higher	
body	mass	index.
Co n c lu s io n s : 	 Depressive	 symptoms	pre-
dicted	higher	IL-6	and	hsCRP	levels	among	
outpatients	 w ith	 coronary	 heart	 disease,	
but	 higher	 inflammation	 levels	 did	 not	




behaviors,	 which	 suggests	 these	 behav-
iors	may	mediate	depressive	effects.
Depression is common in patients with cardiac dis-
ease, with prevalence rates nearly three times as high as in 
the general population (1, 2). Depression is also associated 
with worse cardiac prognosis and greater mortality (3). 
However, there is still considerable debate regarding how 
depression might contribute to a worse cardiac prognosis 
or mortality (4). Inflammation is associated with both car-
diac disease and depression and is a plausible physiologi-
cal link between depression and coronary heart disease. 
Cross-sectional studies have demonstrated an association 
between depression and inflammation in healthy subjects 
(5–9) and in cardiac patients (10, 11), but relatively little 
is known about the directionality of the association (i.e., 
whether depression causes inflammation or vice versa).
Previous studies on the direction of the association be-
tween depression and inflammation have yielded con-
flicting results. Stewart and colleagues (12) examined the 
directionality of the relationship in otherwise healthy sub-
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Millipore Milliplex Map kit (Millipore, Billerica, Mass.), with in-
terassay coefficients of variation from 6.3% to 11.6%. Concentra-
tions of serum fibrinogen were determined by the Clauss assay 
with coefficients of variation less than 3%. We log-transformed 
the hsCRP and IL-6 levels because they were not normally dis-
tributed, and we verified that the transformation resulted in nor-
mal distributions. We also created three separate dichotomous 
variables for IL-6, hsCRP, and fibrinogen, defining a priori a high 
level as one in the highest quartile. For IL-6 a high level was de-
fined as above 5.40 pg/ml, for hsCRP a high level was one above 
3.48 mg/liter, and a high fibrinogen level was defined as above 
420 mg/dl.
O the r A sse ssm en ts
We recorded self-reported age, gender, ethnicity, education, 
and medical history at baseline and at the 5-year examination. 
In addition, we assessed health behaviors known to be associ-
ated with inflammation, such as smoking status, physical activ-
ity, and body mass index (BMI) (20, 21). To assess physical activ-
ity, we asked, “Which of the following statements best describes 
how physically active you have been during the last month, that 
is, done activities such as 15–20 minutes of brisk walking, swim-
ming, general conditioning, or recreational sports?” Participants 
responded by choosing one of the six following categories: not at 
all active, a little active (one or two times per month), fairly active 
(three or four times per month), quite active (one or two times 
per week), very active (three or four times per week), or extremely 
active (five or more times per week). Self-report of physical ac-
tivity has been shown to be valid, accurate, and reliable (22–25). 
Physical inactivity was defined as “not at all active” or “a little ac-
tive.” Height and weight were measured and used to calculate 
BMI (weight in kilograms divided by the square of height in me-
ters). Alcohol consumption was measured with the AUDIT-C self-
report questionnaire (26). Left ventricular ejection fraction was 
assessed by means of two-dimensional echocardiography. High-
density lipoprotein (HDL) levels were measured from fasting ve-
nous blood samples, and non-HDL cholesterol was calculated as 
total cholesterol minus HDL cholesterol. Participants were asked 
to bring all of their medication bottles to the study appointment, 
and all current medications were recorded. Medications were cat-
egorized by using Epocrates Rx (Epocrates, San Mateo, Calif.).
Sta tistica l A na ly se s
The goal of this study was to determine the directionality of 
the depression-inflammation relationship. We used general lin-
ear models to compare mean levels of each marker across three 
groups: participants who were not depressed at any interview 
(having a score below 10 on the Patient Health Questionnaire at 
all interviews), participants who reported depressive symptoms 
(a score of 10 or higher) at one interview, and those who reported 
significant depressive symptoms at two or more interviews.
To further evaluate the association between Patient Health 
Questionnaire score and levels of inflammation, we used multi-
variate analysis of variance adjusted for other patient character-
istics associated with depressive symptoms (age, gender, educa-
tion, race, aspirin use, history of diabetes, myocardial infarction, 
and congestive heart failure) and health behaviors (physical ac-
tivity, smoking, and BMI). In addition, we evaluated change in 
inflammation over 5 years across the three subgroups. Finally, we 
used multivariate analysis of covariance (MANCOVA) to evaluate 
the effect of depressive symptoms on all three measures of in-
flammation as a single dependent variable, adjusted for the base-
line level of inflammation. We also used MANCOVA to evaluate 
the effect of inflammation on subsequent depressive symptoms 
(as a single dependent variable), adjusted for the baseline level of 
depressive symptoms. Analyses were performed by using SAS 9.2 
(SAS Institute, Cary, N.C.).
ated whether depressive symptoms (assessed annually for 
6 years) were associated with higher levels of subsequent 
inflammation and vice versa. In addition, we evaluated 
the role of health behaviors in mediating the association 
between depression and inflammation.
M ethod
Design  and  Pa rtic ipan ts
The Heart and Soul Study is an ongoing prospective cohort 
study of psychosocial factors and health outcomes in patients 
with coronary heart disease. Its methods have been described 
previously (14). Briefly, 1,024 outpatients with stable coronary 
heart disease were recruited and completed a baseline examina-
tion between September 2000 and December 2002. Following the 
baseline examination, patients received annual telephone calls 
for assessment of depressive symptoms. Between September 
2005 and December 2007, 667 participants (80% of the 829 sur-
vivors) completed a 5-year follow-up examination that included 
measures of inflammation. The study protocol was approved by 
the appropriate institutional review boards, and all participants 
provided written informed consent.
Dep re ssive  Sym p tom s
Depressive symptoms were assessed annually for 6 years by 
using the 9-item Patient Health Questionnaire, a self-report in-
strument that measures the frequency of depressive symptoms 
corresponding to the nine DSM-IV criteria for depression (15). A 
paper-and-pencil version of the questionnaire was administered 
at the baseline examination (year 0), telephone versions were ad-
ministered after 1, 2, 3, and 4 years of follow-up, and a paper-and-
pencil version was again administered after 5 years of follow-up. 
Of the 667 participants who were examined at 5 years, 640 com-
pleted five or more interviews, 23 (3.4%) completed four inter-
views, three (0.4%) completed three interviews, and one (0.1%) 
completed two interviews.
At each assessment, participants were asked to indicate the 
frequency of experiencing each depressive symptom during the 
last 2 weeks. Each of the nine symptoms was scored as 0 (not at 
all), 1 (on several days), 2 (more than half the days), or 3 (nearly 
every day), with total scores ranging from 0 to 27 (16). The Pa-
tient Health Questionnaire has demonstrated excellent validity 
when compared with a mental health interview for depression in 
patients with coronary heart disease (17, 18). Telephone and in-
person assessments yield similar results (19). As a summary mea-
sure of depressive symptoms, we calculated the mean score for 
each participant as the sum of the annual questionnaire scores 
divided by the number of interviews completed. We also created a 
categorical variable by defining “depressive symptoms” as a score 
of 10 or higher on the Patient Health Questionnaire. We used this 
to group the participants into three categories: depressive symp-
toms at two or more interviews, depressive symptoms at one in-
terview, or no depressive symptoms. We chose these groups for 
analysis because further divisions would have yielded too few 
participants in each category.
Inflamm ato ry  B iom arke rs
Fasting blood samples were obtained at baseline and after 5 
years of follow-up. Levels of high-sensitivity C-reactive protein 
(hsCRP), IL-6, and fibrinogen were determined from plasma and 
serum samples. The laboratory technicians were blinded to the 
depression status of the participants.
A highly sensitive CRP assay was performed with a BN II neph-
elometer (Dade-Behring, Newark, Del.). Interassay coefficients 
of variation were 1.66%–5.32%. IL-6 was measured by using the 
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myocardial infarction, congestive heart failure, and aspi-
rin use (Table 2). However, after further adjustment for 
health behaviors (physical activity, smoking, and BMI), 
depressive symptoms were no longer associated with 
any inflammation index. When we evaluated the multi-
variable-adjusted mean change in levels of inflammatory 
markers, depressive symptoms did not predict statistically 
significant changes in IL-6, hsCRP, or fibrinogen (Table 3).
When we analyzed depressive symptoms as a con-
tinuous variable, the average score on the Patient Health 
Questionnaire across the annual assessments predict-
ed subsequent log-transformed levels of IL-6 (β=0.102, 
p=0.009) and hsCRP (β=0.121, p=0.002) but not the level of 
fibrinogen (β=0.058, p=0.13). Again, this association was 
no longer significant after adjustment for health behaviors 
(log IL-6: β=0.038, p=0.36; hsCRP: β=0.018, p=0.67; fibrino-
gen: β=0.018, p=0.68).
When inflammation was evaluated as a dichotomous 
variable, the proportions of participants with levels of in-
flammatory markers in the highest quartile were 22% to 
24% in those without depression at any interview, 23% to 
28% in those with depressive symptoms at one interview, 
and 30% to 35% in patients with depressive symptoms at 
two or more interviews (Figure 1).
Inflamm ation  a s P red ic to r o f  Sub sequen t D ep re ssive  
Sym p tom s
MANCOVAs revealed no effect of inflammation on sub-
sequent depression in unadjusted analyses (F=1.37, df=6, 
1256, p=0.22) or after adjustment for age, gender, educa-
tion, race, history of diabetes, myocardial infarction, con-
gestive heart failure, aspirin use, and baseline depres-
sive symptoms (F=0.65, df=6, 1224, p=0.69). In addition, 
baseline levels of inflammatory markers were not associ-
ated with subsequent depressive symptoms (Table 4). As 
compared with participants who had significant depres-
sive symptoms at two or more annual assessments, those 
without depressive symptoms had similar baseline levels 
of log IL-6, log hsCRP, and fibrinogen.
d iscu ssion
The aim of this study was to examine the directionality 
of the depression-inflammation relationship in a group of 
patients with stable coronary heart disease. The rate of de-
pressive symptoms was consistent with the rate in a previ-
ous study (27): 34% of the participants had a score of 10 or 
higher on the Patient Health Questionnaire at one or more 
time points. We found that depressive symptoms were as-
sociated with higher subsequent levels of inflammation, 
whereas baseline levels of inflammation did not predict 
subsequent depressive symptoms. The association be-
tween depressive symptoms and subsequent inflamma-
tion was eliminated after adjustment for health behaviors 
associated with inflammation—physical inactivity, smok-
ing, and higher BMI. Taken together, these findings sug-
gest that depression may lead to inflammation through 
re su lts
Cha ra c te ristic s  o f  Pa rtic ipan ts
As compared with the 162 patients who were alive 
and did not complete the 5-year follow-up examina-
tion, the 667 participants who completed the exam were 
older (mean age=66 years, SD=10, versus mean=64 years, 
SD=12; t=–2.09, df=827, p=0.04) and had fewer baseline 
depressive symptoms as indicated by scores on the Pa-
tient Health Questionnaire (mean=4.75, SD=5.26, versus 
mean=6.77, SD=5.84; t=4.29, df=827, p<0.01). Participants 
who completed the exam also had lower log-transformed 
baseline hsCRP levels (mg/liter) than those who did not 
complete the 5-year exam (mean=0.57, SD=1.29, versus 
mean=0.85, SD=1.32; t=2.48, df=795, p=0.01). Baseline lev-
els of IL-6 and fibrinogen were similar in the patients who 
did and did not complete the 5-year examination (p>0.10 
in both cases).
Of the 667 participants who completed the 5-year ex-
amination, 138 (21%) had depressive symptoms (i.e., a 
score of 10 or higher on the Patient Health Questionnaire) 
at two or more interviews, 86 (13%) had depressive symp-
toms at one interview, and 443 (66%) had no significant 
depressive symptoms (a score less than 10 on the Patient 
Health Questionnaire at all interviews). As compared to 
participants without significant depressive symptoms, 
those with depressive symptoms at any interview were 
younger and less likely to be male, to be white, or to have 
graduated from high school (Table 1). They were more 
likely to have a history of diabetes, myocardial infarction, 
or congestive heart failure and had higher BMI values. 
Participants with depressive symptoms were less likely to 
use aspirin and more likely to smoke and to be physically 
inactive. The three groups had similar levels of hyperten-
sion, cardiac disease severity, cardiac risk factors, and use 
of cardioprotective medications.
P re sence  o f  D ep re ssive  Sym p tom s a s P red ic to r o f  
Sub sequen t Inflamm ation
MANCOVAs evaluating the effect of depression on subse-
quent inflammation showed that depressive symptoms pre-
dicted subsequent inflammation in an unadjusted analysis 
(F=2.56, df=6, 1304, p=0.02) and after adjustment for age, 
gender, education, race, history of diabetes, myocardial in-
farction, congestive heart failure, aspirin use, and baseline 
levels of inflammatory markers (F=2.15, df=6, 1182, p<0.05). 
This association was no longer significant after adjustment 
for health behaviors (F=1.74, df=6, 1128, p=0.11).
Across the three groups, greater depressive symptoms 
were associated with higher subsequent log-transformed 
levels of IL-6 and hsCRP, and they were nonsignificantly 
associated with higher levels of fibrinogen (Table 2). De-
pressive symptoms remained associated with subsequent 
levels of IL-6 and were marginally related to levels of fi-
brinogen but were not associated with hsCRP, after adjust-
ment for age, gender, education, race, history of diabetes, 
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were too bad) and did not include measures of sleep, ap-
petite, concentration, energy, suicidal thoughts, or de-
pressed mood. In contrast, we administered the Patient 
Health Questionnaire, which was specifically designed to 
assess the nine symptoms of depression. Another possible 
explanation for the difference in findings is the difference 
between study populations. The association between de-
pressive symptoms and inflammation in the general pop-
ulation may differ from the relationship in patients with 
established coronary heart disease.
It is interesting that our results show that depressive 
symptoms predicted high levels of hsCRP and IL-6 but not 
fibrinogen. A possible explanation could be that hsCRP 
and IL-6 are more specific for the underlying inflamma-
tion process in stable patients with coronary heart disease. 
In contrast to hsCRP and IL-6, which are both markers of 
inflammation, fibrinogen not only reflects inflammation 
but also is a blood coagulation factor (28), which could 
explain why we did not find a prospective association be-
tween depression and fibrinogen.
We also found that patients with depressive symptoms 
at two or more interviews had higher levels of inflamma-
poor health behaviors, but inflammation does not lead to 
depression in patients with coronary heart disease.
There have been only a few studies regarding the di-
rectionality of the depression-inflammation relationship, 
and to our knowledge, this is the first study on this subject 
in a cardiac population. We also believe this to be the first 
study evaluating the association of depressive symptoms 
over time with subsequent inflammation. Our results 
extend the findings of Stewart and colleagues (12), who 
found that depression predicted high levels of IL-6, where-
as high levels of IL-6 did not predict depression. However, 
our results differ from those of Gimeno and colleagues, 
who reported that CRP and IL-6 levels were predictive of 
subsequent depressive symptoms, but not vice versa, in 
the Whitehall II study (13).
One possible explanation for this discrepancy is that 
the Whitehall II study used a different measure of depres-
sive symptoms. Their assessment was based on four items 
from the General Health Questionnaire (thinking of your-
self as a worthless person, feeling that life is entirely hope-
less, feeling that life is not worth living, and finding times 
when you could not do anything because your nerves 
















Mean SD Mean SD Mean SD F df p
Age	(years) 72.8 9.2 68.6 12.0 66.3 11.0 24.26 2,	661 <0.01
N % N % N % c2 df p
Male 381 86 62 72 106 77 13.18 2 <0.01
White	 277 63 42 49 79 57 6.03 2 0.05
High	school	graduate 402 91 70 81 112 81 13.63 2 <0.01
Comorbid	conditions
Hypertension 324 74 65 77 110 80 2.55 2 0.28
Myocardial	infarction 205 47 53 63 70 51 7.66 2 0.02
Congestive	heart	failure 68 16 17 20 42 31 15.56 2 <0.01
Diabetes	mellitus 122 28 35 41 35 26 7.12 2 0.03
Medication	use
Aspirin 338 76 58 67 86 62 11.40 2 <0.01
Beta-blocker 300 68 62 72 91 66 0.94 2 0.62
Renin-angiotensin	system	inhibitor 298 67 55 64 85 62 1.63 2 0.44
Statin 123 28 20 23 26 19 4.66 2 0.10
Health	behaviors
Regular	alcohol	use 132 30 19 23 32 24 3.24 2 0.20
Current	smoking 42 10 13 16 37 27 25.81 2 <0.01
Physical	inactivity 140 32 41 49 82 60 38.43 2 <0.01
Mean SD Mean SD Mean SD F df p
Body	mass	index	(kg/m2	) 28.1 5.0 29.8 6.0 29.6 7.0 5.59 2,	663 <0.01
Cardiac	disease	severity	and	risk	factors
Left	ventricular	ejection	fraction 0.62 0.11 0.63 0.11 0.60 0.13 1.43 2,	654 <0.01
LDL	cholesterol	(mg/dl) 93.7 34.2 98.0 28.6 95.0 32.9 0.62 2,	653 0.54
HDL	cholesterol	(mg/dl) 47.5 14.8 47.3 18.6 45.6 14.3 0.75 2,	663 <0.01
Non-HDL	cholesterol	 115.7 38.9 124.0 34.1 120.8 37.0 2.28 2,	663 0.10
a	Depressive	symptoms	were	assessed	at	baseline	and	annually	for	the	next	5	years.
b	Total	number	varied	because	data	on	some	variables	were	not	available	for	all	participants.
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single episode of depression. Consistent with these find-
ings are the results of Hamer and colleagues (29), who 
found that in a group of 3,609 aging subjects, participants 
with depressive symptoms at two time points had higher 
levels of CRP and fibrinogen than those with depressive 
tion at follow-up than patients with depressive symptoms 
at one interview. To the extent that depressive symptoms 
at two or more interviews represented chronic or recur-
rent depression, our findings suggest that persistent de-
pression may have greater effects on inflammation than a 
TA BLe  2 . Le ve ls  o f  inflamm ato ry  M arke rs a t 5 -Year Fo llow -Up  in  Pa tien ts  W ith  Co ronary  H eart d isease , b y  d ep re ssive  














Inflammatory	Marker	and	Modelb Mean SD/SEc Mean SD/SEc Mean SD/SEc F df p
Interleukin-6,	log-transformed	(pg/ml)
Unadjusted 1.19 0.66 1.19 0.71 1.38 0.71 4.36 2,	658 0.01
Model	1 1.13 0.06 1.34 0.08 1.51 0.07 4.46 2,	631 0.01
Model	2 1.40 0.06 1.38 0.08 1.52 0.70 1.91 2,	602 0.15
High-sensitivity	C-reactive	protein,	
log-transformed	(mg/liter)
Unadjusted 0.34 1.14 0.58 1.30 0.70 1.30 5.12 2,	658 <0.01
Model	1 0.70 0.11 0.88 0.15 0.90 0.12 1.78 2,	631 0.17
Model	2 0.80 0.12 0.90 0.16 0.91 0.13 0.45 2,	602 0.64
Fibrinogen	(mg/dl)
Unadjusted 371 79 370 87 391 102 2.87 2,	659 0.06
Model	1 385 8 381 11 404 9 2.50 2,	632 0.08





TA BLe  3 . Change  in  inflamm ato ry  M arke r Le ve ls  o ve r 5  Years in  Pa tien ts  W ith  Co ronary  H eart d isease , b y  d ep re ssive  
















Mean SD/SEc Mean SD/SEc Mean SD/SEc F df p
Interleukin-6,	log-transformed	(pg/ml)
Unadjusted 1.24 2.83 1.30 2.82 1.80 3.14 1.87 2,	628 0.16
Model	1 1.45 0.26 1.60 0.35 1.95 0.30 1.33 2,	602 0.26
Model	2 1.43 0.30 1.54 0.39 1.92 0.33 1.11 2,	574 0.33
High-sensitivity	C-reactive	protein,		
log-transformed	(mg/liter)
Unadjusted –0.54 7.74 0.98 12.38 0.26 13.28 1.00 2,	629 0.37
Model	1 –0.85 0.89 0.85 1.23 0.10 1.03 1.12 2,	603 0.33
Model	2 –1.48 1.04 0.57 1.36 –0.18 1.14 1.54 2,	575 0.22
Fibrinogen	(mg/dl)
Unadjusted –13.36 81.72 –16.68 80.52 7.06 102.64 3.10 2,	626 0.05
Model	1 –14.22 7.85 –19.35 11.05 5.07 9.00 2.63 2,	600 0.07
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with stable coronary heart disease that a combination of 
intensive exercise and dietary changes significantly low-
ered levels of IL-6 and CRP, suggesting that physical inac-
tivity and BMI may influence inflammation levels.
Several strengths can be attributed to this study. First, 
the annual assessments of depressive symptoms and 
medical health status presented us with the opportunity 
to assess the direction of this association. In addition, bio-
logical and behavioral mediators were carefully assessed 
at baseline and after 5 years of follow-up. However, there 
are also several limitations. This study focused on outpa-
tients with stable coronary heart disease. Our results may 
therefore not apply to healthy participants or to patients 
with acute coronary syndromes. Furthermore, the study 
group mostly consisted of older men, so these results may 
not be generalizable to either women or younger men. 
Finally, 20% (162 of 829) of the surviving participants did 
not complete the 5-year follow-up examination. However, 
these participants were younger and had worse depres-
sion scores than those who completed the examination, 
so including them would probably have strengthened the 
association between depression and inflammation.
In conclusion, we found no evidence of a bidirection-
al relationship between depression and inflammation. 
Depression was prospectively associated with IL-6 and 
hsCRP, but not vice versa. This prospective association 
was no longer significant after adjustment for physical in-
activity, BMI, and smoking. These findings raise the pos-
sibility that helping depressed cardiac patients improve 
health behaviors could reduce inflammation.
symptoms at one time point. In addition, Kaptein and col-
leagues (30) showed that patients with chronic depressive 
symptoms following myocardial infarction were at high-
er risk for having new cardiovascular events than those 
whose depressive symptoms resolved. Taken together, the 
findings suggest that the duration of depressive symptoms 
may influence cardiac health.
The prospective association of depression with inflam-
mation was no longer significant after adjustment for 
health behaviors (physical inactivity, BMI, and smoking). 
Although our results cannot determine the direction of 
the association between depression and health behaviors, 
this raises the possibility that helping depressed cardiac 
patients improve these behaviors could potentially reduce 
inflammation. These findings are further supported by a 
longitudinal community-based study in which Matthews 
and colleagues (31) investigated the directionality of the 
depression-inflammation relationship among 1,781 pre-
menopausal and early perimenopausal women who were 
free of cardiac disease at baseline. They found that de-
pression, as measured with the Center for Epidemiologic 
Studies Depression Scale, was associated with higher CRP 
levels at follow-up. Similar to our results, this association 
was no longer significant after adjustment for a range of 
covariates including health behaviors. In addition, Ham-
er and colleagues (29) found that weight change, waist 
circumference, current smoking, alcohol use, and espe-
cially physical activity were significant mediators in the 
depression-inflammation relationship. Finally, Dod and 
colleagues (32) showed in a group of nonsmoking patients 
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Clinical Guidance: Depression, Smoking, 
and Heart Disease
Depression was associated with increased inflamma-
tion as measured by elevated levels of interleukin-6 
and high-sensitivity C-reactive protein in patients 
with coronary heart disease from the Heart and Soul 
Study, report Duivis et al. The effect was accounted for 
by the increased body mass index and cigarette smok-
ing associated with depression. Schroe der points out 
in an editorial (p. 876) that effective treatments for 
smoking cessation do not interfere with treatment of 
depression or cause suicide. Treatment of both smok-
ing and depression with bupropion and referral to a 
“quitline” are possible strategies.
